Shopping Cart
- Remove All
Your shopping cart is currently empty
Pardoprunox (SLV-308) is a partial dopamine D2 agonist and noradrenergic agonist with serotonin 5-HT1A agonist properties, used in trials for treating Early Stage Parkinson's Disease and Advanced Stage Parkinson's Disease.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $887 | 4-6 weeks |
| Description | Pardoprunox (SLV-308) is a partial dopamine D2 agonist and noradrenergic agonist with serotonin 5-HT1A agonist properties, used in trials for treating Early Stage Parkinson's Disease and Advanced Stage Parkinson's Disease. |
| Targets&IC50 | D2:8.1(pKi), D3:8.6(pKi), 5-HT1A receptor:6.3 (pEC50) |
| Synonyms | SLV-308, DU-126891 |
| Molecular Weight | 233.27 |
| Formula | C12H15N3O2 |
| Cas No. | 269718-84-5 |
| Smiles | O=C1OC2=C(C=CC=C2N1)N3CCN(C)CC3 |
| Relative Density. | 1.258 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
| Solubility Information | DMSO: 10 mM, Sonication is recommended. | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
| |||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.